Navigation Links
FDA Approves New Test For Screening Infection In Babies

A new test that screens babies for the presence of a common infection was approved by the Food and Drug Administration on Tuesday. Group B streptococcus// is a common infection that is passed from mother to child. It can cause sepsis, pneumonia, meningitis, neurological damage or even death.

Although all women are tested for group B streptococcus during pregnancy, current screening methods can leave some babies at risk for contracting an infection from the bacterium. But the new test, which UF researchers studied for several months as part of a clinical trial, allows health-care workers to quickly screen mothers during labor, improving the odds that babies will receive preventive care so they will not be infected during delivery.

"Without any intervention, (group B strep) is the most common cause of early-onset infection in newborns," said Rodney Edwards, M.D., a UF assistant professor of obstetrics and gynecology in the College of Medicine who led the clinical trial at UF, one of six sites to study the test. "It can cause sepsis, meningitis and pneumonia. The likelihood of dying if you are a newborn is 5 percent. (With meningitis) even if the baby makes it through the infection there is a chance of cerebral palsy and cognitive delay."

The new group B strep test, developed by the California-based company Cepheid, allows doctors to screen for the bacterium during labor. Currently, women are screened for the organism a few weeks before birth because it takes a few days to receive results from the lab. But because some women do not contract the organism until after they are tested, some babies are still at risk for infection.

The first clinical molecular diagnostic test the FDA has approved, the technology can be adapted to detect other infections such as avian flu and even the deadly bug methicillin-resistant Staphylococcus aureus, Cepheid official say.

About one-quarter of women carry group B streptococcus i
'"/>




Page: 1 2 3

Related medicine news :

1. FDA Approves Contraceptive Ring
2. FDA Approves New HIV Drug, Viread
3. FDA Approves Birth Control Skin Patch
4. FDA Approves New Arthritis Drug, Bextra
5. FDA Approves Elidel Cream for Eczema
6. FDA Approves New Anti-Clotting Drug
7. FDA Approves New surgery Treatment for Farsightedness
8. FDA Approves Anti-Cancer Cell Drug - Zevalin
9. FDA Approves Remodulin for Pulmonary Hypertension
10. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
11. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking

Post Your Comments:
(Date:11/9/2009)...gs that inhibit estrogen, , , MONDAY, N...breast cancer and osteoporosis eliminated cervical...e drugs also cleared precancerous growths in the c...r in mice with precancerous lesions. , The brea...steoporosis drug raloxifene were given to mice gen...
(Date:11/9/2009)...ally, study finds, , , MONDAY, Nov. 9 (... drug Plavix (clopidogrel) works about the same in...ials has found. , "After this study, I can say ... with this very important drug," said Dr. Jeffrey ...t New York University Langone Medical Center in Ne...
(Date:11/9/2009)...s everybody,s buzz word today and for Recruiters a...es Recruiters and Staffers create their own privat...te and close positions. The site also enables indi...ork with recruiters. , (P...s everyone to network more than ever and by the la...
(Date:11/9/2009)...uld boost self-esteem, researchers say , ...ldren are more likely to have handwriting problems...thout autism, researchers say. , The new study ...udy participants had autism spectrum disorder, but...e for perceptual reasoning on an IQ test. , The...
(Date:11/9/2009)...ned sexual function, study says, , , ...e able to restore sexual function to rabbits with ...e lab and implanting it, a new study reports. ,...hers say the technique could one day be used to tr...ere able to show the tissue was able to integrate ...
Breaking Medicine News(10 mins):Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3
... , THE JOURNAL OF THE AMERICAN SOCIETY OF PLASTIC ... following is being released by the American Socie... Health Care Spending? , A new study suggests that... is not probable. The author, who completed health...
...HAM, Mass., Jan. 5 , , , WHAT: YEAR-IN-P... , , WHEN: Wednesday, January 7, 2009 11:00 AM...son, Co-president, Millennium Research Group , , ...ary webinar identifying the top 10 trends and even...
...ary is National Hot Tea Month, the Height of the C...is National Hot Tea Month and is also the height o...ates that there will be more than 200,000 American...? , , The CDC strongly recommends an annual flu v...
...USTA, Ga. Just days after the first retinal cell ...tiguous cells start committing suicide and researc...er treatment of this potentially blinding infectio... disease process such as diabetes, said Dr. Sally ...
...CETON, N.J., Jan. 5 BullMarket.com ( http://www.b...ocused on long-term growth and income-generating s...verage on several healthcare IT stocks, including ...olutions (Nasdaq: MDRX ), and McKesson (NYSE: ...
...HIRE, Conn., Jan. 5 Alexion Pharmaceuticals, Inc....d Bell, Chief Executive Officer of Alexion Pharmac...n Healthcare Conference in San Francisco at 4:30 p... webcast at: www.alexionpharm.com . An archived v...
Other Medicine News:Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3Health News:Millennium Research Group's Year-in-Preview Webinar 2Health News:Flu Season is Tea Time 2Health News:Cell death from cytomegalovirus may bring new life to treatment of retinal disease 2Health News:BullMarket.com Examines Healthcare IT Stocks 2
(Date:11/9/2009)...wswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc...cused on the acquisition, development and commerci...oducts for the treatment of life-threatening disea...any"), today announced its results for the third q...r 30, 2009, the Company had cash, cash equivalents...
(Date:11/9/2009)... Groundbreaking articles in current...he first time explore, in depth, the emergence of ...re providers and its potential benefits for patien...of Washington authors, Sunil Aggarwal, PhD who is ...ning Program and who conducted the article,s resea...
(Date:11/9/2009)...., Nov. 9 /PRNewswire/ -- On Sept. 11, 2001, tho...rescue workers came together to save as many lives... Brian McCauley was one of those 9/11 first respon..., Only in his late 30s, McCauley was diagnosed wi...tensive chemotherapy treatments, leaving him confi...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 6Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 1Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 2Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 3MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 1MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 2MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 3MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 4MessageSolution Enterprise Email Archive Named Top Exchange Archiving Solution by Leading Exchange Site MSExchange org 55476 5Mennen Medical Receives Frost 26amp 3B Sullivan 2009 European Patient Monitoring Technology Leadership Award 55472 1Mennen Medical Receives Frost 26amp 3B Sullivan 2009 European Patient Monitoring Technology Leadership Award 55472 2Mennen Medical Receives Frost 26amp 3B Sullivan 2009 European Patient Monitoring Technology Leadership Award 55472 3
...E, Pa., Sept. 18 ,Interleukin Genetics, Inc. (Amex...nced a research collaboration to explore the role ...ion is to develop a series of genetic,tests that w...l,s inherited,resistance to weight loss and, more ...ess with diet and other weight loss techniques., ...
..., September 18 ,Amsterdam Molecular Therapeutics (...e therapy, today announced that it obtained a lice...lopment of a gene therapy treatment for,Parkinson,... proprietary,adeno-associated virus (AAV) gene the...ent of an effective, long-term treatment for this ...
Other Medicine Technology:Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success 2Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success 3AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform 2AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform 3
Rheumatoid Factor ADVIA 1650
Rheumatoid Factor - Liquid Immunoassay Reagents
ACUVUE OASYS with HYDRACLEAR™ PLUS
C-VUE 55 Toric Multifocal Lens
Medicine Products: